New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
BioCryst Pharmaceuticals (BCRX)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2009
30-JUN
2009
30-SEP
2009
31-DEC
2009
31-MAR
2010
Total Revenue
4.36M
4.79M
10.5M
54.9M
26.1M
Cost of Revenue
-410K
-413K
-394K
4.15M
-305K
Gross Profit
4.77M
5.20M
10.9M
50.7M
26.4M
Research & Development
11.3M
11.2M
18.2M
31.6M
24.9M
SG&A
2.46M
2.31M
3.06M
3.65M
3.80M
Amortization & Deprec
410K
413K
394K
396K
391K
Other Expenses
-95K
-55K
-70K
51.6M
-134K
Total Operating Expenses
14.1M
13.9M
21.6M
87.3M
29.0M
Operating Income
-9.29M
-8.68M
-10.6M
-36.5M
-2.60M
Other Income
0
0
0
51.7M
0
EBIT
-9.29M
-8.68M
-10.6M
15.2M
-2.60M
Minority Interest
0
0
0
0
0
Interest Expense
0
0
0
0
0
Income Before Taxes
-9.29M
-8.68M
-10.6M
15.2M
-2.60M
Income Taxes
0
0
0
0
0
Net Income from Continuing Ops
-9.29M
-8.68M
-10.6M
15.2M
-2.60M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
-9.29M
-8.68M
-10.6M
15.2M
-2.60M
Preferred Dividends
0
0
0
0
0
Net Income to Common
-9.29M
-8.68M
-10.6M
15.2M
-2.60M
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉